We’re on a mission to transform the way the world sees the genome. By combining the best-in-class analysis software of BioDiscovery with the structural variant detection power of optical genome mapping, we’re equipping cancer researchers with better tools, expanded services and an expert team. Let’s solve the complexities of cancer together to elevate the health and wellness of all people.
- CGC 2022
One Team. More Solutions.
Working together to reveal more genomic variations that matter in cancer research.
Visit the Bionano booth in the Exhibit Hall to see our solutions for cancer research
One company working together to transform the way the world sees the genome
Finding Community and Connection at CGC
Unraveling the Genomics of Cancer
As part of our mission to elevate the health and wellness of all people, Bionano Genomics takes the fight against cancer personally. We’re committed to playing an important role in service to the cancer research community — building better tools, asking harder questions, and working together to make genomic discoveries that can ultimately lead to better outcomes for people diagnosed with cancer.
Innovative Cancer Science
Bionano Genomics will host a panel discussion around the utility of optical genome mapping in clinical research. Dr. Alka Chaubey and a panel of key opinion leaders will discuss the latest results, publications, clinical research, and laboratory implementation. Topics will range from implementation as an alternative to cytogenetics and cytogenomics to the complementarity to NGS and its utility for HRD scoring.
MD, PhD, FCAP Augusta University
PhD, FACMG Legacy Health
MD, MD Anderson Cancer Center
MSc(Med), PhD, FACMG Columbia University Medical Center & the New York Presbyterian Hospital
Highlighted Scientific Sessions
|Integrating Novel Genomic Alterations for Pathologic Classification and Clinical Risk Assessment in Pediatric and Adult Leukemias||Homologous Recombination DNA Repair Deficiency in Hematological Malignancies||Ha Nguyen|
MD Anderson Cancer Center, School of Health Professions
|Implementation of New and Emerging Technologies in Oncologic Laboratories for Improving Patient Care||International Working Group Recommendations for the Implementation of Optical Genome Mapping in Hematologic Malignancies||Adam Smith|
University Health Network
|Application of High-Depth and Novel Genomic Testing Methodologies in the Comprehensive Analyses of Vascular Anomalies and Somatic Mosaic Disorders||Identification of Novel Genomic Structural Variations In Angiosarcoma by Optical Genome Mapping||Thuy Phung|
University of South Alabama
|Roundtable Discussion||Detection of Gene Rearrangements by Next Generation Sequencing (NGS) and Optical Genome Mapping||Panel|
|Expanded Horizons in Hematologic Malignancies: Clonal Behaviors and Novel Genomic Approaches||Optical Genome Mapping and 523-Gene Sequencing Panel for Comprehensive Genomic Evaluation of Myeloid Cancers||Nikhil Sahajpal|
Beer, Barbeque, Baseball, and Bionano
All CGC attendees and their guests are invited to join us Tuesday evening, August 2 at Salt and Smoke in Ballpark Village, overlooking Busch Stadium.
We’ll be reconnecting with colleagues, watching the Cardinals play the Cubs from the patio, and hitting the dance floor with a live DJ. The party starts at 6:30 pm. No RSVP required. Join us!
Decoding Cancer Complexity
Tools for analysis of detected genomic scars associated with homologous recombination deficiency (HRD) continue to evolve. Don’t miss Dr. Soheil Shams’ scientific presentation detailing the development of new genomic scar analysis.
The latest NxClinical software 6.2 release adds three measures of genomic instability for homologous recombination repair deficiency (HRD) in solid tumors:
- Loss of Heterozygosity (LOH)
- Telomeric Allelic Imbalance (TAI)
- Large-Scale State Transitions (LST)
|Concordance of Integrated Analysis Approaches to Measure Genomic Instability Associated with Homologous Recombination Deficiency (HRD) Using TCGA Ovarian Cancer Dataset||Soheil Shams|
|Use of Optical Genome Mapping and Next Generation Sequencing to Construct a Comprehensive Somatic Variation Map in a Cancer Cell Line||Andy Pang|
|Comparison of optical genome mapping, CMA, and 523-gene NGS panel for Homologous Recombination Deficiency calculation||Nikhil Sahajpal |
|Optical Genome Mapping: Clinical Validation and Diagnostic Utility for Cytogenomic Analysis of Hematological Neoplasms||Nikhil Sahajpal |
|Optical Genome Mapping Workflow for Identification and Analysis of Variants in Hematological Malignancies||James Yu|
|Optical Genome Mapping Workflow for Somatic Abnormality Detection in Multiple Solid Tumor Types||Alex Hastie|
|Optical Genome Mapping Reveals Novel Structural Variants in Pediatric Brain Tumors||Miriam Bornhorst |
Children’s National Health System
|Optical Genome Mapping for Somatic Abnormality Detection in Multiple Solid Tumor Types||Benjamin Clifford |
|Optical Genome Mapping: Unraveling the Genomic Landscape of Solitary Fibrous Tumor||Enrique de Alava |
|Optical Genome Mapping in Acute Myeloid Leukemia: A Multicenter Evaluation||Brynn Levy |
|Optical Genome Mapping for Constitutional Postnatal SV, CNV, and Repeat Array Sizing: A Multi-site Clinical Study||Nikhil Sahajpal |
|Optical Genome Mapping and NGS for Identification of All Classes of Variants||James Yu |